Associations between functional TNFR2 196 M/R polymorphisms and susceptibility to rheumatoid arthritis

a meta-analysis

Gwan Gyu Song, Sang Cheol Bae, Young Ho Lee

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Several studies have examined the effects of tumor necrosis factor receptor (TNFR) 1 +38 A/G and TNFR2 196 M/R polymorphisms on susceptibility to RA and have reported conflicting results. The purpose of this study was to examine whether the TNFR1 +38 A/G and TNFR2 196 M/R polymorphisms are associated with RA susceptibility. We performed a literature search using the Medical Literature Analysis and Retrieval System Online and Embase citation indices, and conducted a meta-analysis to examine the association between the TNFR1 +38 A/G and TNFR2 196 M/R polymorphisms and RA. Our meta-analysis included a total of 13 studies from 11 articles, consisting of 11 studies of the TNFR2 polymorphism (2,092 cases and 1,483 controls), and two studies of the TNFR1 polymorphism (672 cases and 288 controls). The meta-analysis revealed a significant association between the TNFR2 196 RR genotype and RA risk (OR 1.737, 95 % CI 1.275–2.367, P = 4.6 × 10−5). Stratification by ethnicity indicated an association between the TNFR2 196 RR genotype and RA in Europeans (OR 2.054, 95 % CI 1.305–3.232, P = 0.002), but not in East Asians (OR 1.596, 95 % CI 0.642–3.971, P = 0.314). Analysis using a homozygote contrast model showed the same pattern for the TNFR2 196 RR genotype in a European and East Asian population. However, no association was found between the TNFR1 +36 A/G polymorphism and RA in a European population. Our meta-analysis demonstrated that the functional TNFR2 196 M/R polymorphism is associated with susceptibility to RA in the European population.

Original languageEnglish
Pages (from-to)1529-1537
Number of pages9
JournalRheumatology International
Volume34
Issue number11
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Receptors, Tumor Necrosis Factor, Type II
Meta-Analysis
Rheumatoid Arthritis
Receptors, Tumor Necrosis Factor, Type I
Genotype
MEDLARS
Population
Tumor Necrosis Factor Receptors
Homozygote

Keywords

  • Meta-analysis
  • Polymorphism
  • RA
  • TNFR

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this

Associations between functional TNFR2 196 M/R polymorphisms and susceptibility to rheumatoid arthritis : a meta-analysis. / Song, Gwan Gyu; Bae, Sang Cheol; Lee, Young Ho.

In: Rheumatology International, Vol. 34, No. 11, 01.01.2014, p. 1529-1537.

Research output: Contribution to journalArticle

@article{c2771437a4c44ffb8c47ef6e6476ca77,
title = "Associations between functional TNFR2 196 M/R polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis",
abstract = "Several studies have examined the effects of tumor necrosis factor receptor (TNFR) 1 +38 A/G and TNFR2 196 M/R polymorphisms on susceptibility to RA and have reported conflicting results. The purpose of this study was to examine whether the TNFR1 +38 A/G and TNFR2 196 M/R polymorphisms are associated with RA susceptibility. We performed a literature search using the Medical Literature Analysis and Retrieval System Online and Embase citation indices, and conducted a meta-analysis to examine the association between the TNFR1 +38 A/G and TNFR2 196 M/R polymorphisms and RA. Our meta-analysis included a total of 13 studies from 11 articles, consisting of 11 studies of the TNFR2 polymorphism (2,092 cases and 1,483 controls), and two studies of the TNFR1 polymorphism (672 cases and 288 controls). The meta-analysis revealed a significant association between the TNFR2 196 RR genotype and RA risk (OR 1.737, 95 {\%} CI 1.275–2.367, P = 4.6 × 10−5). Stratification by ethnicity indicated an association between the TNFR2 196 RR genotype and RA in Europeans (OR 2.054, 95 {\%} CI 1.305–3.232, P = 0.002), but not in East Asians (OR 1.596, 95 {\%} CI 0.642–3.971, P = 0.314). Analysis using a homozygote contrast model showed the same pattern for the TNFR2 196 RR genotype in a European and East Asian population. However, no association was found between the TNFR1 +36 A/G polymorphism and RA in a European population. Our meta-analysis demonstrated that the functional TNFR2 196 M/R polymorphism is associated with susceptibility to RA in the European population.",
keywords = "Meta-analysis, Polymorphism, RA, TNFR",
author = "Song, {Gwan Gyu} and Bae, {Sang Cheol} and Lee, {Young Ho}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s00296-014-3027-x",
language = "English",
volume = "34",
pages = "1529--1537",
journal = "Rheumatology International",
issn = "0172-8172",
publisher = "Springer Verlag",
number = "11",

}

TY - JOUR

T1 - Associations between functional TNFR2 196 M/R polymorphisms and susceptibility to rheumatoid arthritis

T2 - a meta-analysis

AU - Song, Gwan Gyu

AU - Bae, Sang Cheol

AU - Lee, Young Ho

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Several studies have examined the effects of tumor necrosis factor receptor (TNFR) 1 +38 A/G and TNFR2 196 M/R polymorphisms on susceptibility to RA and have reported conflicting results. The purpose of this study was to examine whether the TNFR1 +38 A/G and TNFR2 196 M/R polymorphisms are associated with RA susceptibility. We performed a literature search using the Medical Literature Analysis and Retrieval System Online and Embase citation indices, and conducted a meta-analysis to examine the association between the TNFR1 +38 A/G and TNFR2 196 M/R polymorphisms and RA. Our meta-analysis included a total of 13 studies from 11 articles, consisting of 11 studies of the TNFR2 polymorphism (2,092 cases and 1,483 controls), and two studies of the TNFR1 polymorphism (672 cases and 288 controls). The meta-analysis revealed a significant association between the TNFR2 196 RR genotype and RA risk (OR 1.737, 95 % CI 1.275–2.367, P = 4.6 × 10−5). Stratification by ethnicity indicated an association between the TNFR2 196 RR genotype and RA in Europeans (OR 2.054, 95 % CI 1.305–3.232, P = 0.002), but not in East Asians (OR 1.596, 95 % CI 0.642–3.971, P = 0.314). Analysis using a homozygote contrast model showed the same pattern for the TNFR2 196 RR genotype in a European and East Asian population. However, no association was found between the TNFR1 +36 A/G polymorphism and RA in a European population. Our meta-analysis demonstrated that the functional TNFR2 196 M/R polymorphism is associated with susceptibility to RA in the European population.

AB - Several studies have examined the effects of tumor necrosis factor receptor (TNFR) 1 +38 A/G and TNFR2 196 M/R polymorphisms on susceptibility to RA and have reported conflicting results. The purpose of this study was to examine whether the TNFR1 +38 A/G and TNFR2 196 M/R polymorphisms are associated with RA susceptibility. We performed a literature search using the Medical Literature Analysis and Retrieval System Online and Embase citation indices, and conducted a meta-analysis to examine the association between the TNFR1 +38 A/G and TNFR2 196 M/R polymorphisms and RA. Our meta-analysis included a total of 13 studies from 11 articles, consisting of 11 studies of the TNFR2 polymorphism (2,092 cases and 1,483 controls), and two studies of the TNFR1 polymorphism (672 cases and 288 controls). The meta-analysis revealed a significant association between the TNFR2 196 RR genotype and RA risk (OR 1.737, 95 % CI 1.275–2.367, P = 4.6 × 10−5). Stratification by ethnicity indicated an association between the TNFR2 196 RR genotype and RA in Europeans (OR 2.054, 95 % CI 1.305–3.232, P = 0.002), but not in East Asians (OR 1.596, 95 % CI 0.642–3.971, P = 0.314). Analysis using a homozygote contrast model showed the same pattern for the TNFR2 196 RR genotype in a European and East Asian population. However, no association was found between the TNFR1 +36 A/G polymorphism and RA in a European population. Our meta-analysis demonstrated that the functional TNFR2 196 M/R polymorphism is associated with susceptibility to RA in the European population.

KW - Meta-analysis

KW - Polymorphism

KW - RA

KW - TNFR

UR - http://www.scopus.com/inward/record.url?scp=84903984723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903984723&partnerID=8YFLogxK

U2 - 10.1007/s00296-014-3027-x

DO - 10.1007/s00296-014-3027-x

M3 - Article

VL - 34

SP - 1529

EP - 1537

JO - Rheumatology International

JF - Rheumatology International

SN - 0172-8172

IS - 11

ER -